Who founded Laplace Interventional?

Laplace Interventional was founded by Ramji Iyer in 2020.

Who are Laplace Interventional's investors?

Laplace Interventional's investors include Aphelion Capital, Features Capital Holdings, gener8tor, ShangBay Capital LLC, Aphelion Cardeation, Engage Venture Partners, Unorthodox Ventures.

How much funding has Laplace Interventional raised?

Laplace Interventional has disclosed $42M raised across 3 rounds.

Where is Laplace Interventional headquartered?

Laplace Interventional is headquartered in Plymouth, US.

Laplace Interventional

Plymouth, US · Founded 2020 · 20 employees on LinkedIn · 7 known investors

Find your way into Laplace Interventional

Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation. The company is a medical device developer based in the United States.

Healthtech Medical Devices

Founders & leadership

Laplace Interventional was founded in 2020 by Ramji Iyer.

Ramji IyerFounder and CEO

Board

Jenny H. BarbaBoard director

Todd MortierBoard director

Colin MorrisonBoard director

Investors · 7

Aphelion Capitallisted by Aphelion Capital

How we know: a partner's Signal profile · press coverage · Not right? Tell us

Features Capital Holdingslisted by Features Capital HoldingsLebanon

How we know: Features Capital Holdings's portfolio page · Not right? Tell us

gener8torlisted by gener8torBeloit

ShangBay Capital LLClisted by ShangBay Capital LLCPalo Alto

How we know: ShangBay Capital LLC's portfolio page · a partner's Signal profile · Not right? Tell us

Aphelion CardeationreportedLittleton

How we know: press coverage · Not right? Tell us

Engage Venture Partnersreported

How we know: funding news · press coverage · Not right? Tell us

Unorthodox VenturesreportedAustin · $1M – $5M

How we know: press coverage · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$42M disclosed across 3 rounds · 2021–2025

▶$21.2MraisedFeb 2025 · 6 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jenny H. BarbaDirector
Todd MortierDirector
Colin MorrisonDirector
Ramji IyerExecutive Officer, Director

Offering amount: $25M
Amount sold: $21.2M
First sale: Feb 2025
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$12.9MraisedJul 2023 · 9 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jenny BarbaDirector
Ramji IyerExecutive Officer, Director
Todd MortierDirector
William DaiDirector

Offering amount: $12.9M
Amount sold: $12.9M
First sale: Jul 2023
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$7.9MraisedSep 2021 · 8 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Ramji IyerExecutive Officer, Director

Offering amount: $7.9M
Amount sold: $7.9M
Minimum investment: $25K
First sale: Aug 2021
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Edwards Lifesciences5 shared keywordsEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.

Rf Surgical5 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Vumedi4 shared keywordsVumedi operates a peer-to-peer video education platform where clinicians watch lectures and technique videos across dozens of medical specialties. It partners with academic institutions, hospitals, and life sciences companies to provide continuing medical education content to doctors.

TipRanks4 shared keywordsFinancial analysis and stock research platform.

Companies competing with Laplace Interventional for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Laplace Interventional – Weekly Recap - TipRanks.comtipranks.com · May 2026

Laplace: $22 Million Raised For Transcatheter Tricuspid Valve Technologypulse2.com · Mar 2025

Laplace Interventional Inc. Announces Series C Financing of $22M for its Transcatheter Tricuspid Valve Technology - BioSpacebiospace.com · Mar 2025

Laplace raises funding to complete study of tricuspid valve technologyfinance.yahoo.com · Mar 2025

Laplace Interventional Raises $22M in Series C Fundingfinsmes.com · Mar 2025

Frequently asked questions

What does Laplace Interventional do?: Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation. The company is a medical device developer based in the United States.
Who founded Laplace Interventional?: Laplace Interventional was founded by Ramji Iyer in 2020.
Who are Laplace Interventional's investors?: Laplace Interventional's investors include Aphelion Capital, Features Capital Holdings, gener8tor, ShangBay Capital LLC, Aphelion Cardeation, Engage Venture Partners, Unorthodox Ventures.
How much funding has Laplace Interventional raised?: Laplace Interventional has disclosed $42M raised across 3 rounds.
Where is Laplace Interventional headquartered?: Laplace Interventional is headquartered in Plymouth, US.